Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Infection
86%
Neutralizing Antibody
33%
Helicobacter Pylori
33%
Antimicrobial Resistance
33%
Extended Spectrum Beta Lactamase
33%
Escherichia coli
33%
Population Study
22%
Antimalarial Agent
22%
Parasitemia
22%
Urinary Tract Infection
20%
Prevalence
18%
Campylobacter
16%
Infectious Agent
13%
Diabetes Mellitus
13%
Urease
11%
Virulence Factor
11%
Cross Sectional Study
11%
Malaria
11%
Mixed Infection
11%
Luciferase
10%
Enzyme-Linked Immunosorbent Assay
8%
Mortality Rate
8%
Plasmodium falciparum
8%
Biocontainment
6%
Fusion Inhibitor
6%
Antivirus Agent
6%
Tropical Disease
6%
Health Status
6%
Antibiotic Therapy
6%
Ceftriaxone
6%
Nitrofurantoin
6%
Antibiotics
6%
Diseases
6%
Bacterial Virulence
5%
Jejunum Ulcer
5%
Nucleic Acid
5%
Disease
5%
Gastrointestinal Symptom
5%
DNA
5%
Helicobacter Infection
5%
Etiology
5%
Abdominal Cancer
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Polymerase Chain Reaction
39%
Trypanosoma
33%
Adipose Tissue
33%
Neutralizing Antibody
33%
Helicobacter Pylori
33%
Immune Response
33%
Adoptive Immunity
33%
Infectious Disease
33%
Antimicrobial Resistance
33%
Escherichia coli
33%
COVID-19
28%
Urinary Tract
25%
Prevalence
21%
Campylobacter
14%
Plasmid
13%
Infectious Agent
13%
Parasitology
11%
Spike
10%
Virulence Factor
9%
Mortality Rate
8%
Plasmodium falciparum
8%
ELISA
8%
Immunomodulation
8%
Memory B Cell
8%
T Cell
8%
B Cell Activation
8%
Immunology
8%
Disk Diffusion
8%
Antibiotic Sensitivity
8%
Natural Host
7%
Blood Plasma
6%
Medline
6%
One Health
6%
Web of Science
6%
Health Status
6%
Medicine and Dentistry
Systematic Review
66%
Infection
50%
Severe Acute Respiratory Syndrome Coronavirus 2
47%
COVID-19
36%
Neutralizing Antibody
33%
Diagnosis
33%
Plasmid
13%
Polymerase Chain Reaction
13%
Rapid Diagnostic Test
13%
Low and Middle Income Countries
13%
Public Health
13%
Pathogen
13%
Molecular Diagnostics
13%
Luciferase
10%
Antimalarial Agent
9%
Parasitemia
9%
Population Research
9%
Community Health
9%
Entry Inhibitor
6%
Biocontainment
6%
Antivirus Agent
6%
Tropical Disease
6%
Health Status
6%
One Health
6%